Cardiovascular actions of vanadate in the genetically obese Zucker rat.
Hopfner
R L
RL
Cardiovascular Risk Factor Reduction Unit, University of Saskatchewan, Saskatoon, Canada.
Misurski
D A
DA
McNeill
J R
JR
Gopalakrishnan
V
V
D000818:Animals; D001013:Aorta, Thoracic / Q000187:drug effects; D001786:Blood Glucose / Q000378:metabolism; D001794:Blood Pressure / Q000187:drug effects; D004730:Endothelium, Vascular / Q000187:drug effects / Q000502:physiology; D002149:Energy Intake / Q000502:physiology; D006439:Hemodynamics / Q000187:drug effects*; D007004:Hypoglycemic Agents / Q000494:pharmacology; D066298:In Vitro Techniques; D007328:Insulin / Q000097:blood / Q000494:pharmacology; D007537:Isometric Contraction / Q000187:drug effects; D008297:Male; D009131:Muscle, Smooth, Vascular / Q000187:drug effects; D009765:Obesity / Q000235:genetics* / Q000378:metabolism / Q000503:physiopathology*; D051381:Rats; D011924:Rats, Zucker; D014638:Vanadates / Q000494:pharmacology*; D015430:Weight Gain / Q000187:drug effects
D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D014638:Vanadates